Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/90465
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHarford-Wright, E.-
dc.contributor.authorLewis, K.-
dc.contributor.authorVink, R.-
dc.contributor.authorGhabriel, M.N.-
dc.date.issued2014-
dc.identifier.citationNeuroscience, 2014; 261:85-94-
dc.identifier.issn0306-4522-
dc.identifier.issn1873-7544-
dc.identifier.urihttp://hdl.handle.net/2440/90465-
dc.description.abstractAbstract not available-
dc.description.statementofresponsibilityE. Harford-Wright, K. M. Lewis, R. Vink and M. N. Ghabriel-
dc.language.isoen-
dc.publisherElsevier-
dc.rights© 2014 IBRO. Published by Elsevier Ltd. All rights reserved.-
dc.source.urihttp://dx.doi.org/10.1016/j.neuroscience.2013.12.027-
dc.subjectNeuropeptides; brain tumors; NK1 antagonist; substance P; cancer therapy-
dc.titleEvaluating the role of substance P in the growth of brain tumors-
dc.typeJournal article-
dc.identifier.doi10.1016/j.neuroscience.2013.12.027-
pubs.publication-statusPublished-
dc.identifier.orcidVink, R. [0000-0002-4885-0667]-
dc.identifier.orcidGhabriel, M.N. [0000-0002-9153-271X]-
Appears in Collections:Aurora harvest 7
Medical Sciences publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.